These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 25345238)

  • 41. An evidence-based review of the clinical use of sertraline in mood and anxiety disorders.
    Sheehan DV; Kamijima K
    Int Clin Psychopharmacol; 2009 Mar; 24(2):43-60. PubMed ID: 21456103
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Suicidal behaviour in youths with depression treated with new-generation antidepressants: meta-analysis.
    Dubicka B; Hadley S; Roberts C
    Br J Psychiatry; 2006 Nov; 189():393-8. PubMed ID: 17077427
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Association between antidepressant half-life and the risk of suicidal ideation or behavior among children and adolescents: confirmatory analysis and research implications.
    Smith EG
    J Affect Disord; 2009 Apr; 114(1-3):143-8. PubMed ID: 18692250
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antidepressant-Induced Activation in Children and Adolescents: Risk, Recognition and Management.
    Luft MJ; Lamy M; DelBello MP; McNamara RK; Strawn JR
    Curr Probl Pediatr Adolesc Health Care; 2018 Feb; 48(2):50-62. PubMed ID: 29358037
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Are antidepressants associated with new-onset suicidality in bipolar disorder? A prospective study of participants in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD).
    Bauer MS; Wisniewski SR; Marangell LB; Chessick CA; Allen MH; Dennehy EB; Miklowitz DJ; Thase ME; Sachs GS
    J Clin Psychiatry; 2006 Jan; 67(1):48-55. PubMed ID: 16426088
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmacotherapy of child and adolescent depression.
    Moreno C; Roche AM; Greenhill LL
    Child Adolesc Psychiatr Clin N Am; 2006 Oct; 15(4):977-98, x. PubMed ID: 16952771
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Impact of the 2004 Food and Drug Administration pediatric suicidality warning on antidepressant and psychotherapy treatment for new-onset depression.
    Valluri S; Zito JM; Safer DJ; Zuckerman IH; Mullins CD; Korelitz JJ
    Med Care; 2010 Nov; 48(11):947-54. PubMed ID: 20856141
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Suicidal risk from TADS study was higher than it first appeared.
    Högberg G; Antonuccio DO; Healy D
    Int J Risk Saf Med; 2015; 27(2):85-91. PubMed ID: 26410011
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antidepressants for people with epilepsy and depression.
    Maguire MJ; Weston J; Singh J; Marson AG
    Cochrane Database Syst Rev; 2014 Dec; 2014(12):CD010682. PubMed ID: 25464360
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Sertraline: a review of its use in the management of major depressive disorder in elderly patients.
    Muijsers RB; Plosker GL; Noble S
    Drugs Aging; 2002; 19(5):377-92. PubMed ID: 12093324
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A double-blind efficacy and safety study of duloxetine fixed doses in children and adolescents with major depressive disorder.
    Emslie GJ; Prakash A; Zhang Q; Pangallo BA; Bangs ME; March JS
    J Child Adolesc Psychopharmacol; 2014 May; 24(4):170-9. PubMed ID: 24815533
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Suicidality and aggression during antidepressant treatment: systematic review and meta-analyses based on clinical study reports.
    Sharma T; Guski LS; Freund N; Gøtzsche PC
    BMJ; 2016 Jan; 352():i65. PubMed ID: 26819231
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A double-blind efficacy and safety study of duloxetine flexible dosing in children and adolescents with major depressive disorder.
    Atkinson SD; Prakash A; Zhang Q; Pangallo BA; Bangs ME; Emslie GJ; March JS
    J Child Adolesc Psychopharmacol; 2014 May; 24(4):180-9. PubMed ID: 24813026
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical features of patients with treatment-emergent suicidal behavior following initiation of paroxetine therapy.
    Kraus JE; Horrigan JP; Carpenter DJ; Fong R; Barrett PS; Davies JT
    J Affect Disord; 2010 Jan; 120(1-3):40-7. PubMed ID: 19439363
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Spotlight on sertraline in the management of major depressive disorder in elderly patients.
    Muijsers RB; Plosker GL; Noble S
    CNS Drugs; 2002; 16(11):789-94. PubMed ID: 12383038
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Antidepressants and Suicidality: A Contradiction?].
    Hatzinger M
    Praxis (Bern 1994); 2019; 108(7):487-494. PubMed ID: 31136275
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Efficacy of sertraline in the treatment of children and adolescents with major depressive disorder: two randomized controlled trials.
    Wagner KD; Ambrosini P; Rynn M; Wohlberg C; Yang R; Greenbaum MS; Childress A; Donnelly C; Deas D;
    JAMA; 2003 Aug; 290(8):1033-41. PubMed ID: 12941675
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Relationship between antidepressants and suicide attempts: an analysis of the Veterans Health Administration data sets.
    Gibbons RD; Brown CH; Hur K; Marcus SM; Bhaumik DK; Mann JJ
    Am J Psychiatry; 2007 Jul; 164(7):1044-9. PubMed ID: 17606656
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The use of antidepressants to treat depression in children and adolescents.
    Cheung AH; Emslie GJ; Mayes TL
    CMAJ; 2006 Jan; 174(2):193-200. PubMed ID: 16415467
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Developmentally informed pharmacotherapy for child and adolescent depressive disorders.
    Sakolsky D; Birmaher B
    Child Adolesc Psychiatr Clin N Am; 2012 Apr; 21(2):313-25, viii. PubMed ID: 22537729
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.